Advanced search
Publication Cover
Journal of Chemotherapy Volume 26, 2014 - Issue 5
Submit an article Journal homepage
55
Views
3
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

Combination of low-dose gemcitabine in 6-hour infusion and carboplatin is a favorable option for patients in poor performance status with advanced non-small cell lung cancer

Zhi-Yong WuDepartment of Medical OncologyShantou Central Hospital, Shantou Hospital, Sun Yat-sen University, Shantou, GD, P.R. China
,
Hui-Hong GuanDepartment of Medical OncologyShantou Central Hospital, Shantou Hospital, Sun Yat-sen University, Shantou, GD, P.R. China
,
Ze-Xiao LinThe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, GD, P.R. China
,
Hong-Kai YangDepartment of Medical OncologyShantou Central Hospital, Shantou Hospital, Sun Yat-sen University, Shantou, GD, P.R. China
,
Lan ZhouDepartment of Medical OncologyShantou Central Hospital, Shantou Hospital, Sun Yat-sen University, Shantou, GD, P.R. China
&
Qi-Chun CaiDepartment of Medical OncologyGuangdong General Hospital, Guangdong Academy of Medical Sciences of China, Guangzhou, GD, P.R. ChinaCorrespondence[email protected]
Pages 306-311 | Published online: 06 Dec 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dehua Zhao, Jing Chen, Mingming Chu & Jisheng Wang. (2019) Prolonged low-dose infusion for gemcitabine: a systematic review. OncoTargets and Therapy 12, pages 4859-4868.
Read now

Articles from other publishers (2)

Zhao Dehua, Chu Mingming & Wang Jisheng. (2018) Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer. PLOS ONE 13:3, pages e0193814.
Crossref
L.G. Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva & A.I. Vorob'ev. (2017) Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome. Clinical oncohematology 10:3, pages 366-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.